Wise, Jonathan
3 papers on CoChat
Most cited papers
- Verified
Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: the DEPICT-1 52-week study
Dandona, P., Mathieu, C., Phillip, M., Hansen, L., Tschöpe, D., Thorén, F., Xu, J., Langkilde, A. M., DEPICT-1 Investigators, Proietto, J., et al. (2018) · Diabetes Care
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 243
- Verified
Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis
Agarwal, R., Tu, W., Farjat, A. E., Farag, Y. M. K., Toto, R., Kaul, S., Lawatscheck, R., Rohwedder, K., Ruilope, L. M., Rossing, P., et al. (2023) · Annals of Internal Medicine
Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension
Cited by 109
- Verified
Efficacy and safety of once-daily insulin degludec/insulin aspart versus insulin glargine (u100) for 52 weeks in insulin-naïve patients with type 2 diabetes: A randomized controlled trial
Kumar, A., Franek, E., Wise, J., Niemeyer, M., Mersebach, H., & Simó, R. (2016) · PLOS ONE
Diabetes Treatment and ManagementDiabetes Management and Research
Cited by 38
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free